PCR Markets: Global Analysis and Opportunity Evaluation 2016 - 2020
Laboratory Markets Limited has completed a comprehensive market study of the global use of PCR covering established, recently developed and more specialised PCR methods and applications used in both clinical and research laboratory settings. PCR 2016 profiles the use of these methods across more than 23,000 clinical and research organisations, encompassing 12 global regions and 158 countries. Details of these end-user organisations by name are provided as part of this report.
These new findings are the result of a detailed three-year market study by Laboratory Markets Limited, covering the period up until May 2016. These leading market data are combined and analysed alongside findings on PCR growth and end-user costs from four other independent market studies, carried out by Laboratory Markets Limited. These four studies involved the participation of more than 1,700 PCR end-users.
Data presented in PCR 2016 are from more than 75,000 PCR clinical and research studies carried out by experienced PCR end-users. These end-users are major decision-makers in the selection and purchase of PCR-related products and these 'real world' market data give in-depth information on the current and future use of PCR, in addition to % growth, costs, trends and opportunities.
End-user organisations by name are identified in all key sectors and segments of this market study. Findings are provided as a PDF report, together with the full PCR 2016 market database created and compiled during this extensive market study. The data provided enables PCR suppliers to easily and rapidly identify, analyse and profile areas of the PCR market that offer the greatest business opportunities to their own companies.
The extensive market database provided with the report augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all PCR markets. This database can be shared across all departments and subsidiaries of purchasing organisations.
These new study findings provide a considerable wealth of market information to suppliers in the PCR, molecular biology and molecular diagnostics fields. They assist suppliers to identify new PCR market opportunities and give powerful strategic insights into new developments and applications.
Key Features 1. Enables suppliers to profile key areas of PCR markets relating to their own PCR products and services and provides qualified prospects by end-user organisation name 2. Analyses and ranks PCR practices by country, organisation type, methods, applications, disease and research areas, viruses, bacteria and others, helping suppliers to identify 'high opportunity' sectors relevant to their current PCR products and future plans in these fields, supporting targeted marketing and reducing costs and risks 3. Provides key information in growing and developing areas of the PCR market, helping suppliers focus resources on PCR growth areas, supporting new sales opportunities in important market sectors 4. Helps suppliers to evolve and extend their own strategic visions, future plans and operational activities in the PCR field 5. Enables suppliers to identify, analyse and rank end-user practices and needs and build new customer relationships in leading PCR market sectors
These new findings are the result of a detailed three-year market study by Laboratory Markets Limited, covering the period up until May 2016. These leading market data are combined and analysed alongside findings on PCR growth and end-user costs from four other independent market studies, carried out by Laboratory Markets Limited. These four studies involved the participation of more than 1,700 PCR end-users.
Data presented in PCR 2016 are from more than 75,000 PCR clinical and research studies carried out by experienced PCR end-users. These end-users are major decision-makers in the selection and purchase of PCR-related products and these 'real world' market data give in-depth information on the current and future use of PCR, in addition to % growth, costs, trends and opportunities.
End-user organisations by name are identified in all key sectors and segments of this market study. Findings are provided as a PDF report, together with the full PCR 2016 market database created and compiled during this extensive market study. The data provided enables PCR suppliers to easily and rapidly identify, analyse and profile areas of the PCR market that offer the greatest business opportunities to their own companies.
The extensive market database provided with the report augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all PCR markets. This database can be shared across all departments and subsidiaries of purchasing organisations.
These new study findings provide a considerable wealth of market information to suppliers in the PCR, molecular biology and molecular diagnostics fields. They assist suppliers to identify new PCR market opportunities and give powerful strategic insights into new developments and applications.
Key Features 1. Enables suppliers to profile key areas of PCR markets relating to their own PCR products and services and provides qualified prospects by end-user organisation name 2. Analyses and ranks PCR practices by country, organisation type, methods, applications, disease and research areas, viruses, bacteria and others, helping suppliers to identify 'high opportunity' sectors relevant to their current PCR products and future plans in these fields, supporting targeted marketing and reducing costs and risks 3. Provides key information in growing and developing areas of the PCR market, helping suppliers focus resources on PCR growth areas, supporting new sales opportunities in important market sectors 4. Helps suppliers to evolve and extend their own strategic visions, future plans and operational activities in the PCR field 5. Enables suppliers to identify, analyse and rank end-user practices and needs and build new customer relationships in leading PCR market sectors
CHAPTER 1. PCR 2016
1.1 Conduct of study
1.2 Data Analysis
1.3 Study Data
CHAPTER 2. GLOBAL PCR
2.1 Global Regions
Figure 2.1. The global use of PCR (all regions and PCR methods 2013 to 2016)
Table 2.1. The global use of PCR (all regions and PCR methods 2013 to 2016)
Figure 2.2. The use of PCR in North America (all PCR methods 2013 to 2016)
Table 2.2. The use of PCR in North America (all PCR methods 2013 to 2016)
Figure 2.3. The use of PCR in Europe (all PCR methods 2013 to 2016)
Table 2.3. The use of PCR in Europe (all PCR methods 2013 to 2016)
Figure 2.4. The use of PCR in Asia (all PCR methods 2013 to 2016)
Table 2.4. The use of PCR in Asia (all PCR methods 2013 to 2016)
Figure 2.5. The use of PCR in South America (all PCR methods 2013 to 2016)
Table 2.5. The use of PCR in South America (all PCR methods 2013 to 2016)
Figure 2.6. The use of PCR in Middle East (all PCR methods 2013 to 2016)
Table 2.6. The use of PCR in Middle East (all PCR methods 2013 to 2016)
Figure 2.7. The use of PCR in Oceania (all PCR methods 2013 to 2016)
Table 2.7. The use of PCR in Oceania (all PCR methods 2013 to 2016)
Figure 2.8. The use of PCR in Central America (all PCR methods 2013 to 2016)
Table 2.8. The use of PCR in Central America (all PCR methods 2013 to 2016)
Figure 2.9. The use of PCR in North Africa (all PCR methods 2013 to 2016)
Table 2.9. The use of PCR in North Africa (all PCR methods 2013 to 2016)
2.2 Organisation Types
Figure 2.10. Top-10 PCR organisation types (all regions and PCR methods 2013 to 2016)
Table 2.10. Top-10 PCR organisation types (all regions and PCR methods 2013 to 2016)
2.3 PCR Methods
Figure 2.11. Top-10 PCR methods (all regions and PCR methods 2013 to 2016)
Table 2.11. Top-10 PCR methods (all regions and PCR methods 2013 to 2016)
2.4 PCR Applications
Figure 2.12. Top-10 PCR applications (all regions and PCR applications 2013 to 2016)
Table 2.12. Top-10 PCR applications (all regions and PCR applications 2013 to 2016)
2.5 PCR Clinical & Research
Figure 2.13. Clinical /research use pf PCR (all regions and PCR applications 2013 to 2016)
Table 2.13. Clinical/Research use of PCR (all regions and PCR applications 2013 to 2016)
2.6 Diseases
Figure 2.14. PCR disease areas (all regions and PCR applications 2013 to 2016)
Table 2.14. PCR disease areas (all regions and PCR applications 2013 to 2016)
2.7 Viruses by PCR
Figure 2.15. PCR virus areas (all regions and PCR applications 2013 to 2016)
Table 2.15. PCR virus areas (all regions and PCR applications 2013 to 2016)
2.8 Bacteria by PCR
Figure 2.16. PCR bacteria areas (all regions and PCR applications 2013 to 2016)
Table 2.16. PCR bacteria areas (all regions and PCR applications 2013 to 2016)
2.9 Nucleic Acids
Figure 2.17. PCR nucleic acid types (all regions and PCR applications 2013 to 2016)
Table 2.17. PCR nucleic acid types (all regions and PCR applications 2013 to 2016)
2.10 Departments
Figure 2.18. PCR departments (all regions and PCR applications 2013 to 2016)
Table 2.18. PCR departments (all regions and PCR applications 2013 to 2016)
2.11 Nucleic Acids
Figure 2.19. PCR departments (all regions and PCR applications 2013 to 2016)
Table 2.19. PCR departments (all regions and PCR applications 2013 to 2016)
2.12 Other Molecular Techniques
Figure 2.20. Other techniques (all regions and PCR applications 2013 to 2016)
Table 2.20. Other techniques (all regions and PCR applications 2013 to 2016)
2.12 Conclusions
CHAPTER 3. PCR BY COUNTRY
3.1 Countries
Figure 3.1. PCR use by country (Top-10 countries and PCR methods 2013 to 2016)
Table 3.1. PCR use by country (Top-15 countries 2013 to 2016)
3.2 Organisation types
Figure 3.2. PCR organisation types [country 1] (Top-10 organisations, all PCR 2013 to 2016)
Table 3.2. PCR organisation types [country 1] (Top-25 organisations, all PCR 2013 to 2016)
3.3 Cities
Figure 3.3. PCR cities in [country 1] (Top-10 cities 2013 to 2016)
Table 3.3. PCR cities in [country 1] (Top 25 cities 2013 to 2016)
3.4 PCR Methods
Figure 3.4. PCR techniques in [country 1] (Top-10 techniques 2013 to 2016)
Table 3.4. PCR techniques in [country 1] (Top-25 techniques 2013 to 2016)
3.5 PCR Applications
Figure 3.5. PCR applications in [country 1] (Top-10 applications 2013 to 2016)
Table 3.5. PCR applications in [country 1] (Top-25 applications 2013 to 2016)
3.6 Clinical & Research
Figure 3.6. Clinical/Research PCR in [country 1] (Clinical/Research 2013 to 2016)
Table 3.6. Clinical/Research PCR in [country 1] (Clinical/Research 2013 to 2016)
3.7 Diseases
Figure 3.7. PCR disease areas in [country 1] (Top-10 disease areas 2013 to 2016)
Table 3.7. PCR disease areas in [country 1] (Top-25 disease areas 2013 to 2016)
3.8 Viruses
Figure 3.8. PCR viruses in [country 1] (Top-10 virus areas 2013 to 2016)
Table 3.8. PCR virus areas in [country 1] (Top-25 virus areas 2013 to 2016)
3.9 Bacteria
Figure 3.9. PCR bacteria in [country 1] (Top-10 bacteria areas 2013 to 2016)
Table 3.9. PCR bacteria areas in [country 1] (Top-25 bacteria areas 2013 to 2016)
3.10 Nucleic Acids
Figure 3.10. PCR nucleic acid types in [country 1] (Top-10 nucleic acids 2013 to 2016)
Table 3.10. PCR nucleic acid types in [country 1] (Top-25 nucleic acids 2013 to 2016)
3.11 PCR Departments
Figure 3.11. PCR departments in [country 1] (Top-10 departments 2013 to 2016)
Table 3.11. PCR departments in [country 1] (Top-25 departments 2013 to 2016)
3.12 Other Techniques
Figure 3.12. Other techniques in [country 1] (Top-10 other techniques 2013 to 2016)
Table 3.12. Other techniques in [country 1] (Top-25 other techniques 2013 to 2016)
3.13 Conclusions
CHAPTER 4. ORGANISATION TYPES
Figure 4.1. PCR by organisation types (Top-10 organisation types, PCR 2013 to 2016)
Table 4.1. PCR by organisation types (Top-10 organisation types, PCR 2013 to 2016)
4.2 Cities
Figure 4.2. PCR cities [OrgType 1] (Top-10 cities, PCR 2013 to 2016)
Table 4.2. PCR cities [OrgType 1] (Top-25 PCR cities, PCR 2013 to 2016)
4.3 PCR Methods
Figure 4.3. PCR techniques [OrgType 1] (Top-10 techniques, PCR 2013 to 2016)
Table 4.3. PCR techniques [OrgType 1] (Top-25 techniques, PCR 2013 to 2016)
4.4 PCR Applications
Figure 4.4. PCR applications [OrgType 1] (Top-10 applications, PCR 2013 to 2016)
Table 4.4. PCR applications [OrgType 1] (Top-25 applications, PCR 2013 to 2016)
4.5 Clinical & Research
Figure 4.5. PCR clinical/research [OrgType 1] (clinical/research, PCR 2013 to 2016)
Table 4.5. PCR clinical/research [OrgType 1] (clinical/research, PCR 2013 to 2016)
4.6 Diseases
Figure 4.6. PCR disease areas [OrgType 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 4.6. PCR disease areas [OrgType 1] (Top-25 disease areas, PCR 2013 to 2016)
4.7 Viruses
Figure 4.7. PCR viruses [OrgType 1] (Top-10 viruses, PCR 2013 to 2016)
Table 4.7. PCR viruses [OrgType 1] (Top-25 viruses, PCR 2013 to 2016)
4.8 Bacteria
Figure 4.8. PCR bacteria [OrgType 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 4.8. PCR bacteria [OrgType 1] (Top-25 bacteria, PCR 2013 to 2016)
4.9 Nucleic Acids
Figure 4.9. PCR nucleic acids [OrgType 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 4.9. PCR nucleic acids [OrgType 1] (Top-25 nucleic acids, PCR 2013 to 2016)
4.10 PCR Departments
Figure 4.10. PCR by end-user departments [OrgType 1] (Top-10 departments, PCR 2013 to 2016)
Table 4.10. PCR by end-user departments [OrgType 1] (Top-10 departments, PCR 2013 to 2016)
4.11 Other Techniques
Figure 4.11. Other techniques [OrgType 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 4.11. Other techniques [OrgType 1] (Top-25 other techniques, PCR 2013 to 2016)
4.12 Conclusions
CHAPTER 5. PCR BY USER DEPARTMENTS
Figure 5.1. PCR use by department (Top-10 departments, all PCR 2013 to 2016)
Table 5.1. PCR use by department (Top-25 departments, all PCR 2013 to 2016)
5.1 Organisation types
Figure 5.2. PCR organisations of [Dept 1] (Top-10 organisation, PCR 2013 to 2016)
Table 5.2. PCR organisations of [Dept 1] (Top-25 organisation, PCR 2013 to 2016)
5.2 States and Cities
Figure 5.3. PCR cities [Dept 1] (Top-10 cities, PCR 2013 to 2016)
Table 5.3. PCR cities [Dept 1] (Top-25 PCR cities, PCR 2013 to 2016)
5.3 Techniques
Figure 5.5. PCR techniques [Dept 1] (Top-10 techniques, PCR 2013 to 2016)
Table 5.5. PCR techniques [Dept 1] (Top-25 techniques, PCR 2013 to 2016)
5.4 Applications
Figure 5.5. PCR applications [Dept 1] (Top-10 applications, PCR 2013 to 2016)
Table 5.5. PCR applications [Dept 1] (Top-25 applications, PCR 2013 to 2016)
5.5 Clinical & Research
Figure 5.6. PCR clinical/research [Dept 1] (clinical/research, PCR 2013 to 2016)
Table 5.6. PCR clinical/research [Dept 1] (clinical/research, PCR 2013 to 2016)
5.6 Diseases
Figure 5.7. PCR disease areas [Dept 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 5.7. PCR disease areas [Dept 1] (Top-25 disease areas, PCR 2013 to 2016)
5.7 Viruses
Figure 5.8. PCR viruses [Dept 1] (Top-10 viruses, PCR 2013 to 2016)
Table 5.8. PCR viruses [Dept 1] (Top-25 viruses, PCR 2013 to 2016)
5.8 Bacteria
Figure 5.9. PCR bacteria [Dept 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 5.9. PCR bacteria [Dept 1] (Top-25 bacteria, PCR 2013 to 2016)
5.9 Nucleic Acids
Figure 5.10. PCR nucleic acids [Dept 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 5.10. PCR nucleic acids [Dept 1] (Top-25 nucleic acids, PCR 2013 to 2016)
5.10 Other Techniques
Figure 5.11. Other techniques [Dept 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 5.10. Other techniques [Dept 1] (Top-25 other techniques, PCR 2013 to 2016)
5.11 Conclusions
CHAPTER 6. PCR METHODS
Figure 6.1. PCR methods (Top-10 methods, all PCR 2013 to 2016)
Table 6.1. PCR methods (Top-25 methods, all PCR 2013 to 2016)
6.1 Organisation types
Figure 6.2. PCR organisations of [Method 1] (Top-10 organisation, PCR 2013 to 2016)
Table 6.2. PCR organisations of [Method 1] (Top-25 organisation, PCR 2013 to 2016)
6.2 Countries
Figure 6.3. PCR countries [Method 1] (Top-10 countries, PCR 2013 to 2016)
Table 6.3. PCR countries [Method 1] (Top-25 countries, PCR 2013 to 2016)
6.3 Organisation types
Figure 6.4. PCR organisations [Method 1] (Top-10 organisation, PCR 2013 to 2016)
Table 6.4. PCR organisations [Method 1] (Top-25 organisation, PCR 2013 to 2016)
6.4 Cities
Figure 6.6. PCR cities [Method 1] (Top-10 cities, PCR 2013 to 2016)
Table 6.6. PCR cities [Method 1] (Top-25 cities, PCR 2013 to 2016)
6.5 Clinical & Research
Figure 6.6. PCR clinical/research [Method 1] (PCR clinical/research, PCR 2013 to 2016)
Table 6.6. PCR clinical/research [Method 1] (PCR clinical/research, PCR 2013 to 2016)
6.6 Diseases
Figure 6.7. PCR disease areas [Method 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 6.7. PCR disease areas [Method 1] (Top-25 disease areas, PCR 2013 to 2016)
6.7 Viruses
Figure 6.8. PCR viruses [Method 1] (Top-10 viruses, PCR 2013 to 2016)
Table 6.8. PCR viruses of [Method 1] (Top-25 viruses, PCR 2013 to 2016)
6.8 Bacteria
Figure 6.9. PCR bacteria [Method 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 6.9. PCR bacteria of [Method 1] (Top-25 bacteria, PCR 2013 to 2016)
6.9 Nucleic Acids
Figure 6.10. PCR nucleic acids [Method 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 6.10. PCR nucleic acids [Method 1] (Top-25 nucleic acids, PCR 2013 to 2016)
6.10 Departments
Figure 6.11. PCR departments [Method 1] (Top-10 departments, PCR 2013 to 2016)
Table 6.11. PCR departments of [Method 1] (Top-25 departments, PCR 2013 to 2016)
6.11 Other Techniques
Figure 6.12. Other techniques [Method 1] (Top-10 techniques, PCR 2013 to 2016)
Table 6.12. Other techniques [Method 1] (Top-25 techniques, PCR 2013 to 2016)
6.12 Conclusions
CHAPTER 7. PCR APPLICATIONS
Figure 7.1. PCR applications (Top-10 applications, all PCR 2013 to 2016)
Table 7.1. PCR applications (Top-25 applications, all PCR 2013 to 2016)
7.1 Organisation types
Figure 7.2. PCR organisations of [App 1] (Top-10 organisations, PCR 2013 to 2016)
Table 7.2. PCR organisations of [App 1] (Top-25 organisation, PCR 2013 to 2016)
7.2 Cities
Figure 7.3. PCR cities [App 1] (Top-10 cities, PCR 2013 to 2016)
Table 7.3. PCR cities [App 1] (Top-25 cities, PCR 2013 to 2016)
7.3 Techniques
Figure 7.4. PCR techniques of [App 1] (Top-10 techniques, PCR 2013 to 2016)
Table 7.4. PCR techniques of [App 1] (Top-25 techniques, PCR 2013 to 2016)
7.4 Clinical & Research
Figure 7.5. Clinical/Research [App 1] (Clinical/Research, PCR 2013 to 2016)
Table 7.5. Clinical/Research [App 1] (Clinical/Research, PCR 2013 to 2016)
7.5 Diseases
Figure 7.7. PCR disease areas [App 1] (PCR disease areas, PCR 2013 to 2016)
Table 7.7. PCR disease areas [App 1] (Top-25 disease areas, PCR 2013 to 2016)
7.6 Viruses
Figure 7.7. PCR viruses [App 1] (Top-10 viruses, PCR 2013 to 2016)
Table 7.7. PCR viruses of [App 1] (Top-25 viruses, PCR 2013 to 2016)
7.7 Bacteria
Figure 7.8. PCR bacteria [App 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 7.8. PCR bacteria of [App 1] (Top-25 bacteria, PCR 2013 to 2016)
7.81 Nucleic Acids
Figure 7.9. PCR nucleic acids [App 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 7.9. PCR nucleic acids of [App 1] (Top-25 nucleic acids, PCR 2013 to 2016)
7.9 Departments
Figure 7.10. PCR departments [App 1] (Top-10 departments, PCR 2013 to 2016)
Table 7.10. PCR departments of [App 1] (Top-25 departments, PCR 2013 to 2016)
7.10 Other Techniques
Figure 7.11. Other techniques [App 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 7.11. Other techniques [App 1] (Top-25 other techniques, PCR 2013 to 2016)
7.11 Conclusions
CHAPTER 8. DISEASE AREAS
Figure 8.1. PCR disease areas (Top-10 disease areas, all PCR 2013 to 2016)
Table 8.1. PCR disease areas (Top-25 disease areas, all PCR 2013 to 2016)
8.1 Organisation types
Figure 8.2. PCR organisations of [Disease 1] (Top-10 organisations, PCR 2013 to 2016)
Table 8.2. PCR organisations of [Disease 1] (Top-25 organisation, PCR 2013 to 2016)
8.1 Countries
Figure 8.3. PCR countries [Disease 1] (Top-10 countries, PCR 2013 to 2016)
Table 8.3. PCR countries of [Disease 1] (Top-25 countries, PCR 2013 to 2016)
8.3 Cities
Figure 8.4. PCR cities [Disease 1] (Top-10 cities, PCR 2013 to 2016)
Table 8.4. PCR cities of [Disease 1] (Top-25 cities, PCR 2013 to 2016)
8.4 Methods
Figure 8.5. PCR methods [Disease 1] (Top-10 methods, PCR 2013 to 2016)
Table 8.5. PCR methods of [Disease 1] (Top-25 methods, PCR 2013 to 2016)
8.5 Applications
Figure 8.6. PCR application [Disease 1] (Top-10 application, PCR 2013 to 2016)
Table 8.6. PCR application of [Disease 1] (Top-25 application, PCR 2013 to 2016)
8.6 Clinical & Research
Figure 8.8. PCR Clinical/Research [Disease 1] (Clinical/Research, PCR 2013 to 2016)
Table 8.8. Clinical/Research [Disease 1] (Top-25 Clinical/Research, PCR 2013 to 2016)
8.7 Viruses
Figure 8.8. PCR viruses [Disease 1] (Top-10 viruses, PCR 2013 to 2016)
Table 8.8. PCR viruses [Disease 1] (Top-25 viruses, PCR 2013 to 2016)
8.8 Bacteria
Figure 8.9. PCR bacteria [Disease 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 8.9. PCR bacteria [Disease 1] (Top-25 bacteria, PCR 2013 to 2016)
8.9 Nucleic Acids
Figure 8.10. PCR nucleic acids [Disease 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 8.10. PCR nucleic acids [Disease 1] (Top-25 nucleic acids, PCR 2013 to 2016)
8.10 Departments
Figure 8.11. PCR departments [Disease 1] (Top-10 departments, PCR 2013 to 2016)
Table 8.11. PCR departments of [Disease 1] (Top-25 departments, PCR 2013 to 2016)
8.11 Other Techniques
Figure 8.12. Other techniques [Disease 1] (Top-10 techniques, PCR 2013 to 2016)
Table 8.12. PCR techniques of [Disease 1] (Top-25 techniques, PCR 2013 to 2016)
8.12 Conclusions
CHAPTER 9. VIRUSES
Figure 9.1. PCR viruses (Top-10 viruses, all PCR 2013 to 2016)
Table 9.1. PCR viruses (Top-25 viruses, all PCR 2013 to 2016)
9.1 Organisation types
Figure 9.2. PCR organisations of [Virus 1] (Top-10 organisations, PCR 2013 to 2016)
Table 9.2. PCR organisations of [Virus 1] (Top-25 organisation, PCR 2013 to 2016)
9.2 Cities
Figure 9.3. PCR cities [Virus 1] (Top-10 cities, PCR 2013 to 2016)
Table 9.3. PCR cities of [Virus 1] (Top-25 cities, PCR 2013 to 2016)
9.3 Methods
Figure 9.4. PCR methods [Virus 1] (Top-10 methods, PCR 2013 to 2016)
Table 9.4. PCR methods of [Virus 1] (Top-25 methods, PCR 2013 to 2016)
9.4 Applications
Figure 9.5. PCR applications [Virus 1] (Top-10 applications, PCR 2013 to 2016)
Table 9.5. PCR applications of [Virus 1] (Top-25 applications, PCR 2013 to 2016)
9.5 Clinical & Research
Figure 9.6. Clinical/Research [Virus 1] (Clinical/Research, PCR 2013 to 2016)
Table 9.6. Clinical/Research [Virus 1] (Clinical/Research, PCR 2013 to 2016)
9.6 Diseases
Figure 9.7. PCR disease areas [Virus 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 9.7. PCR disease areas [Virus 1] (Top-25 disease areas, PCR 2013 to 2016)
9.7 Bacteria
Figure 9.9. PCR bacteria [Virus 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 9.9. PCR bacteria of [Virus 1] (Top-25 bacteria, PCR 2013 to 2016)
9.8 Nucleic Acids
Figure 9.9. PCR nucleic acids [Virus 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 9.9. PCR nucleic acids [Virus 1] (Top-25 nucleic acids, PCR 2013 to 2016)
9.9 Departments
Figure 9.10. PCR departments [Virus 1] (Top-10 departments, PCR 2013 to 2016)
Table 9.10. PCR departments [Virus 1] (Top-25 departments, PCR 2013 to 2016)
9.10 Other Techniques
Figure 9.11. Other techniques [Virus 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 9.11. Other techniques [Virus 1] (Top-25 other techniques, PCR 2013 to 2016)
9.11 Conclusions
CHAPTER 10. BACTERIA
Figure 10.1. PCR viruses (Top-10 viruses, all PCR 2013 to 2016)
Table 10.1. PCR viruses (Top-25 viruses, all PCR 2013 to 2016)
10.1 Countries
Figure 10.2. PCR countries [Bacteria 1] (Top-10 countries, PCR 2013 to 2016)
Table 10.2. PCR countries [Bacteria 1] (Top-25 countries, PCR 2013 to 2016)
10.2 Organisation types
Figure 10.3 Organisation types [Bacteria 1] (Top-10 organisations, PCR 2013 to 2016)
Table 10.3. Organisation types [Bacteria 1] (Top-10 organisations, PCR 2013 to 2016)
10.3 Cities
Figure 10.4. PCR cities [Bacteria 1] (Top-10 cities, PCR 2013 to 2016)
Table 10.4. PCR cities [Bacteria 1] (Top-25 cities, PCR 2013 to 2016)
10.4 Techniques
Figure 10.5. PCR techniques [Bacteria 1] (Top-10 techniques, PCR 2013 to 2016)
Table 10.5. PCR techniques [Bacteria 1] (Top-25 techniques, PCR 2013 to 2016)
10.5 Applications
Figure 10.6. PCR applications [Bacteria 1] (Top-10 applications, PCR 2013 to 2016)
Table 10.6. PCR applications [Bacteria 1] (Top-25 applications, PCR 2013 to 2016)
10.6 Clinical & Research
Figure 10.7. Clinical/Research [Bacteria 1] (Clinical/Research, PCR 2013 to 2016)
Table 10.7. Clinical/Research [Bacteria 1] (Clinical/Research, PCR 2013 to 2016)
10.7 Diseases
Figure 10.8. PCR disease areas [Bacteria 1] (PCR disease areas, PCR 2013 to 2016)
Table 10.8. PCR disease areas [Bacteria 1] (PCR disease areas, PCR 2013 to 2016)
10.8 Viruses
Figure 10.10. PCR viruses [Bacteria 1] (Top-10 viruses, PCR 2013 to 2016)
Table 10.10. PCR viruses [Bacteria 1] (Top-25 viruses, PCR 2013 to 2016)
10.9 Nucleic Acids
Figure 10.10. PCR nucleic acids [Bacteria 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 10.10. PCR nucleic acids [Bacteria 1] (Top-25 nucleic acids, PCR 2013 to 2016)
10.10 Departments
Figure 10.11. PCR departments [Bacteria 1] (Top-10 departments, PCR 2013 to 2016)
Table 10.11. PCR departments [Bacteria 1] (Top-25 departments, PCR 2013 to 2016)
10.11 Other Techniques
Figure 10.12. Other techniques [Bacteria 1] (Top-10 techniques, PCR 2013 to 2016)
Table 10.12. Other techniques [Bacteria 1] (Top-25 techniques, PCR 2013 to 2016)
10.12 Conclusions
CHAPTER 11. CLINICAL AND RESEARCH
Figure 11.1. Clinical (Top-10 PCR methods, all PCR 2013 to 2016)
Table 11.1. Clinical (Top-25 PCR methods, all PCR 2013 to 2016)
Figure 11.2. Research (Top-10 PCR methods, all PCR 2013 to 2016)
Table 11.2. Research (Top-25 PCR methods, all PCR 2013 to 2016)
11.1 Countries
Figure 11.3. PCR countries [Clinical] (Top-10 countries, PCR 2013 to 2016)
Table 11.3. PCR countries [Clinical] (Top-25 countries, PCR 2013 to 2016)
Figure 11.4. PCR countries [Research] (Top-10 countries, PCR 2013 to 2016)
Table 11.4. PCR countries [Research] (Top-25 countries, PCR 2013 to 2016)
11.2 Organisation types
Figure 11.5. PCR organisation types [Clinical] (Top-10 organisations, PCR 2013 to 2016)
Table 11.5. PCR organisation types [Clinical] (Top-25 organisations, PCR 2013 to 2016)
Figure 11.6. PCR organisation types [Research] (Top-10 organisations, PCR 2013 to 2016)
Table 11.6. PCR organisation types [Research] (Top-25 organisations, PCR 2013 to 2016)
11.3 Cities
Figure 11.7. PCR cities [Clinical] (Top-10 cities, PCR 2013 to 2016)
Table 11.7. PCR cities [Clinical] (Top-25 cities, PCR 2013 to 2016)
Figure 11.8. PCR cities [Research] (Top-10 cities, PCR 2013 to 2016)
Table 11.8. PCR cities [Research] (Top-25 cities, PCR 2013 to 2016)
11.4 Methods
Figure 11.9. PCR methods [Clinical] (Top-10 methods, PCR 2013 to 2016)
Table 11.9. PCR methods [Clinical] (Top-25 methods, PCR 2013 to 2016)
Figure 11.11. PCR methods [Research] (Top-10 methods, PCR 2013 to 2016)
Table 11.11. PCR methods [Research] (Top-25 methods, PCR 2013 to 2016)
11.5 Applications
Figure 11.11. PCR applications [Clinical] (Top-10 applications, PCR 2013 to 2016)
Table 11.11. PCR applications [Clinical] (Top-25 applications, PCR 2013 to 2016)
Figure 11.12. PCR applications [Research] (Top-10 applications, PCR 2013 to 2016)
Table 11.12. PCR applications [Research] (Top-25 applications, PCR 2013 to 2016)
11.6 Diseases
Figure 11.13. PCR diseases [Clinical] (Top-10 diseases, PCR 2013 to 2016)
Table 11.13. PCR diseases [Clinical] (Top-25 diseases, PCR 2013 to 2016)
Figure 11.14. PCR diseases [Research] (Top-10 diseases, PCR 2013 to 2016)
Table 11.14. PCR diseases [Research] (Top-25 diseases, PCR 2013 to 2016)
11.7 Viruses
Figure 11.15. PCR viruses [Clinical] (Top-10 viruses, PCR 2013 to 2016)
Table 11.15. PCR viruses [Clinical] (Top-25 viruses, PCR 2013 to 2016)
Figure 11.16. PCR viruses [Research] (Top-10 viruses, PCR 2013 to 2016)
Table 11.16. PCR viruses [Research] (Top-25 viruses, PCR 2013 to 2016)
11.8 Bacteria
Figure 11.17. PCR bacteria [Clinical] (Top-10 bacteria, PCR 2013 to 2016)
Table 11.17. PCR bacteria [Clinical] (Top-25 bacteria, PCR 2013 to 2016)
Figure 11.18. PCR bacteria [Research] (Top-10 bacteria, PCR 2013 to 2016)
Table 11.18. PCR bacteria [Research] (Top-25 bacteria, PCR 2013 to 2016)
11.9 Nucleic Acids
Figure 11.19. PCR nucleic acids [Clinical] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 11.19. PCR nucleic acids [Clinical] (Top-25 nucleic acids, PCR 2013 to 2016)
Figure 11.20. PCR nucleic acids [Research] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 11.20. PCR nucleic acids [Research] (Top-25 nucleic acids, PCR 2013 to 2016)
11.10 Departments
Figure 11.21. PCR departments [Clinical] (Top-10 departments, PCR 2013 to 2016)
Table 11.21. PCR departments [Clinical] (Top-25 departments, PCR 2013 to 2016)
Figure 11.22. PCR departments [Research] (Top-10 departments, PCR 2013 to 2016)
Table 11.22. PCR departments [Research] (Top-25 departments, PCR 2013 to 2016)
11.11 Other Techniques
Figure 11.23. Other techniques [Clinical] (Top-10 other techniques, PCR 2013 to 2016)
Table 11.23. Other techniques [Clinical] (Top-25 other techniques, PCR 2013 to 2016)
Figure 11.24. Other techniques [Research] (Top-10 other techniques, PCR 2013 to 2016)
Table 11.24. Other techniques [Research] (Top-25 other techniques, PCR 2013 to 2016)
11.12 Conclusions
CHAPTER 12. NUCLEIC ACIDS
Figure 12.1. PCR nucleic acids (Top-10 nucleic acids, all PCR 2013 to 2016)
Table 12.1. PCR nucleic acids (Top-25 nucleic acids, all PCR 2013 to 2016)
12.1 Countries
Figure 12.2. PCR countries [Nucleic Acid 1] (Top-10 countries, PCR 2013 to 2016)
Table 12.2. PCR countries [Nucleic Acid 1] (Top-25 countries, PCR 2013 to 2016)
12.2 Organisation types
Figure 12.3. PCR organisation types [Nucleic Acid 1] (Top-10 organisations types, PCR 2013 to 2016)
Table 12.3. PCR organisation types [Nucleic Acid 1] (Top-25 organisations types, PCR 2013 to 2016)
12.3 Cities
Figure 12.4. PCR cities [Nucleic Acid 1] (Top-10 cities, PCR 2013 to 2016)
Table 12.4. PCR cities types [Nucleic Acid 1] (Top-25 cities types, PCR 2013 to 2016)
12.4 Techniques
Figure 12.5. PCR methods [Nucleic Acid 1] (Top-10 methods, PCR 2013 to 2016)
Table 12.5. PCR methods [Nucleic Acid 1] (Top-25 methods, PCR 2013 to 2016)
12.5 Applications
Figure 12.6. PCR applications [Nucleic Acid 1] (Top-10 applications, PCR 2013 to 2016)
Table 12.6. PCR applications [Nucleic Acid 1] (Top-25 applications, PCR 2013 to 2016)
12.6 Clinical & Research
Figure 12.7. Clinical/Research [Nucleic Acid 1] (clinical/research, PCR 2013 to 2016)
Table 12.7. Clinical/Research [Nucleic Acid 1] (clinical/research, PCR 2013 to 2016)
12.7 Diseases
Figure 12.8. PCR disease areas [Nucleic Acid 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 12.8. PCR disease areas [Nucleic Acid 1] (Top-25 disease areas, PCR 2013 to 2016)
12.8 Viruses
Figure 12.9. PCR viruses [Nucleic Acid 1] (Top-10 viruses, PCR 2013 to 2016)
Table 12.9. PCR viruses [Nucleic Acid 1] (Top-25 viruses, PCR 2013 to 2016)
12.9 Bacteria
Figure 12.10. PCR bacteria [Nucleic Acid 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 12.10. PCR bacteria [Nucleic Acid 1] (Top-25 bacteria, PCR 2013 to 2016)
12.10 Nucleic Acids
Figure 12.12. PCR nucleic acids [Nucleic Acid 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 12.12. PCR nucleic acids [Nucleic Acid 1] (Top-25 nucleic acids, PCR 2013 to 2016)
12.11 Departments
Figure 12.12. PCR departments [Nucleic Acid 1] (Top-10 departments, PCR 2013 to 2016)
Table 12.12. PCR departments [Nucleic Acid 1] (Top-25 departments, PCR 2013 to 2016)
12.12 Other Techniques
Figure 12.13. Other molecular techniques [Nucleic Acid 1] (Top-10 techniques, PCR 2013 to 2016)
Table 12.13. Other molecular techniques [Nucleic Acid 1] (Top-25 techniques, PCR 2013 to 2016)
12.13 Conclusions
CHAPTER 13. OTHER MOLECULAR TECHNIQUES
Figure 13.1. PCR nucleic acids (Top-10 nucleic acids, all PCR 2013 to 2016)
Table 13.1. PCR nucleic acids (Top-25 nucleic acids, all PCR 2013 to 2016)
13.1 Countries
Figure 13.2. PCR countries [Other Technique 1] (Top-10 countries, PCR 2013 to 2016)
Table 13.2. PCR countries [Other Technique 1] (Top-25 countries, PCR 2013 to 2016)
13.2 Organisation types
Figure 13.3. PCR organisation types [Other Technique 1] (Top-10 organisations, PCR 2013 to 2016)
Table 13.3. PCR organisation types [Other Technique 1] (Top-25 organisations, PCR 2013 to 2016)
13.3 Cities
Figure 13.4. PCR cities [Other Technique 1] (Top-10 cities PCR 2013 to 2016)
Table 13.4. PCR cities [Other Technique 1] (Top-25 cities PCR 2013 to 2016)
13.4 Applications
Figure 13.5. PCR applications [Other Technique 1] (Top-10 applications PCR 2013 to 2016)
Table 13.5. PCR applications [Other Technique 1] (Top-25 applications PCR 2013 to 2016)
13.5 Clinical & Research
Figure 13.6. PCR cities [Other Technique 1] (Top-10 cities PCR 2013 to 2016)
Table 13.6. PCR cities [Other Technique 1] (Top-25 cities PCR 2013 to 2016)
13.6 Diseases
Figure 13.7. PCR disease areas [Other Technique 1] (Top-10 disease areas PCR 2013 to 2016)
Table 13.7. PCR disease areas [Other Technique 1] (Top-25 disease areas PCR 2013 to 2016)
13.7 Viruses
Figure 13.8. PCR viruses [Other Technique 1] (Top-10 viruses PCR 2013 to 2016)
Table 13.8. PCR viruses [Other Technique 1] (Top-25 viruses PCR 2013 to 2016)
13.8 Bacteria
Figure 13.9. PCR bacteria [Other Technique 1] (Top-10 bacteria PCR 2013 to 2016)
Table 13.9. PCR bacteria [Other Technique 1] (Top-25 bacteria PCR 2013 to 2016)
13.9 Nucleic Acids
Figure 13.10. PCR nucleic acids [Other Technique 1] (Top-10 nucleic acids PCR 2013 to 2016)
Table 13.10. PCR nucleic acids [Other Technique 1] (Top-25 nucleic acids PCR 2013 to 2016)
13.10 Departments
Figure 13.11. PCR departments [Other Technique 1] (Top-10 departments PCR 2013 to 2016)
Table 13.11. PCR departments [Other Technique 1] (Top-25 departments PCR 2013 to 2016)
13.11 Other Techniques
Figure 13.13. Other molecular techniques [Other Technique 1] (Top-10 techniques PCR 2013 to 2016)
Table 13.13. Other molecular techniques [Other Technique 1] (Top-25 techniques PCR 2013 to 2016)
13.12 Conclusions
CHAPTER 14. DISCUSSION
14.1 Top PCR Markets and Opportunities
14.2 PCR Growth and Opportunities
14.3 PCR Qualified Prospects and Opportunities
14.4 PCR End-User Costs
14.5 Key Findings
1.1 Conduct of study
1.2 Data Analysis
1.3 Study Data
CHAPTER 2. GLOBAL PCR
2.1 Global Regions
Figure 2.1. The global use of PCR (all regions and PCR methods 2013 to 2016)
Table 2.1. The global use of PCR (all regions and PCR methods 2013 to 2016)
Figure 2.2. The use of PCR in North America (all PCR methods 2013 to 2016)
Table 2.2. The use of PCR in North America (all PCR methods 2013 to 2016)
Figure 2.3. The use of PCR in Europe (all PCR methods 2013 to 2016)
Table 2.3. The use of PCR in Europe (all PCR methods 2013 to 2016)
Figure 2.4. The use of PCR in Asia (all PCR methods 2013 to 2016)
Table 2.4. The use of PCR in Asia (all PCR methods 2013 to 2016)
Figure 2.5. The use of PCR in South America (all PCR methods 2013 to 2016)
Table 2.5. The use of PCR in South America (all PCR methods 2013 to 2016)
Figure 2.6. The use of PCR in Middle East (all PCR methods 2013 to 2016)
Table 2.6. The use of PCR in Middle East (all PCR methods 2013 to 2016)
Figure 2.7. The use of PCR in Oceania (all PCR methods 2013 to 2016)
Table 2.7. The use of PCR in Oceania (all PCR methods 2013 to 2016)
Figure 2.8. The use of PCR in Central America (all PCR methods 2013 to 2016)
Table 2.8. The use of PCR in Central America (all PCR methods 2013 to 2016)
Figure 2.9. The use of PCR in North Africa (all PCR methods 2013 to 2016)
Table 2.9. The use of PCR in North Africa (all PCR methods 2013 to 2016)
2.2 Organisation Types
Figure 2.10. Top-10 PCR organisation types (all regions and PCR methods 2013 to 2016)
Table 2.10. Top-10 PCR organisation types (all regions and PCR methods 2013 to 2016)
2.3 PCR Methods
Figure 2.11. Top-10 PCR methods (all regions and PCR methods 2013 to 2016)
Table 2.11. Top-10 PCR methods (all regions and PCR methods 2013 to 2016)
2.4 PCR Applications
Figure 2.12. Top-10 PCR applications (all regions and PCR applications 2013 to 2016)
Table 2.12. Top-10 PCR applications (all regions and PCR applications 2013 to 2016)
2.5 PCR Clinical & Research
Figure 2.13. Clinical /research use pf PCR (all regions and PCR applications 2013 to 2016)
Table 2.13. Clinical/Research use of PCR (all regions and PCR applications 2013 to 2016)
2.6 Diseases
Figure 2.14. PCR disease areas (all regions and PCR applications 2013 to 2016)
Table 2.14. PCR disease areas (all regions and PCR applications 2013 to 2016)
2.7 Viruses by PCR
Figure 2.15. PCR virus areas (all regions and PCR applications 2013 to 2016)
Table 2.15. PCR virus areas (all regions and PCR applications 2013 to 2016)
2.8 Bacteria by PCR
Figure 2.16. PCR bacteria areas (all regions and PCR applications 2013 to 2016)
Table 2.16. PCR bacteria areas (all regions and PCR applications 2013 to 2016)
2.9 Nucleic Acids
Figure 2.17. PCR nucleic acid types (all regions and PCR applications 2013 to 2016)
Table 2.17. PCR nucleic acid types (all regions and PCR applications 2013 to 2016)
2.10 Departments
Figure 2.18. PCR departments (all regions and PCR applications 2013 to 2016)
Table 2.18. PCR departments (all regions and PCR applications 2013 to 2016)
2.11 Nucleic Acids
Figure 2.19. PCR departments (all regions and PCR applications 2013 to 2016)
Table 2.19. PCR departments (all regions and PCR applications 2013 to 2016)
2.12 Other Molecular Techniques
Figure 2.20. Other techniques (all regions and PCR applications 2013 to 2016)
Table 2.20. Other techniques (all regions and PCR applications 2013 to 2016)
2.12 Conclusions
CHAPTER 3. PCR BY COUNTRY
3.1 Countries
Figure 3.1. PCR use by country (Top-10 countries and PCR methods 2013 to 2016)
Table 3.1. PCR use by country (Top-15 countries 2013 to 2016)
3.2 Organisation types
Figure 3.2. PCR organisation types [country 1] (Top-10 organisations, all PCR 2013 to 2016)
Table 3.2. PCR organisation types [country 1] (Top-25 organisations, all PCR 2013 to 2016)
3.3 Cities
Figure 3.3. PCR cities in [country 1] (Top-10 cities 2013 to 2016)
Table 3.3. PCR cities in [country 1] (Top 25 cities 2013 to 2016)
3.4 PCR Methods
Figure 3.4. PCR techniques in [country 1] (Top-10 techniques 2013 to 2016)
Table 3.4. PCR techniques in [country 1] (Top-25 techniques 2013 to 2016)
3.5 PCR Applications
Figure 3.5. PCR applications in [country 1] (Top-10 applications 2013 to 2016)
Table 3.5. PCR applications in [country 1] (Top-25 applications 2013 to 2016)
3.6 Clinical & Research
Figure 3.6. Clinical/Research PCR in [country 1] (Clinical/Research 2013 to 2016)
Table 3.6. Clinical/Research PCR in [country 1] (Clinical/Research 2013 to 2016)
3.7 Diseases
Figure 3.7. PCR disease areas in [country 1] (Top-10 disease areas 2013 to 2016)
Table 3.7. PCR disease areas in [country 1] (Top-25 disease areas 2013 to 2016)
3.8 Viruses
Figure 3.8. PCR viruses in [country 1] (Top-10 virus areas 2013 to 2016)
Table 3.8. PCR virus areas in [country 1] (Top-25 virus areas 2013 to 2016)
3.9 Bacteria
Figure 3.9. PCR bacteria in [country 1] (Top-10 bacteria areas 2013 to 2016)
Table 3.9. PCR bacteria areas in [country 1] (Top-25 bacteria areas 2013 to 2016)
3.10 Nucleic Acids
Figure 3.10. PCR nucleic acid types in [country 1] (Top-10 nucleic acids 2013 to 2016)
Table 3.10. PCR nucleic acid types in [country 1] (Top-25 nucleic acids 2013 to 2016)
3.11 PCR Departments
Figure 3.11. PCR departments in [country 1] (Top-10 departments 2013 to 2016)
Table 3.11. PCR departments in [country 1] (Top-25 departments 2013 to 2016)
3.12 Other Techniques
Figure 3.12. Other techniques in [country 1] (Top-10 other techniques 2013 to 2016)
Table 3.12. Other techniques in [country 1] (Top-25 other techniques 2013 to 2016)
3.13 Conclusions
CHAPTER 4. ORGANISATION TYPES
Figure 4.1. PCR by organisation types (Top-10 organisation types, PCR 2013 to 2016)
Table 4.1. PCR by organisation types (Top-10 organisation types, PCR 2013 to 2016)
4.2 Cities
Figure 4.2. PCR cities [OrgType 1] (Top-10 cities, PCR 2013 to 2016)
Table 4.2. PCR cities [OrgType 1] (Top-25 PCR cities, PCR 2013 to 2016)
4.3 PCR Methods
Figure 4.3. PCR techniques [OrgType 1] (Top-10 techniques, PCR 2013 to 2016)
Table 4.3. PCR techniques [OrgType 1] (Top-25 techniques, PCR 2013 to 2016)
4.4 PCR Applications
Figure 4.4. PCR applications [OrgType 1] (Top-10 applications, PCR 2013 to 2016)
Table 4.4. PCR applications [OrgType 1] (Top-25 applications, PCR 2013 to 2016)
4.5 Clinical & Research
Figure 4.5. PCR clinical/research [OrgType 1] (clinical/research, PCR 2013 to 2016)
Table 4.5. PCR clinical/research [OrgType 1] (clinical/research, PCR 2013 to 2016)
4.6 Diseases
Figure 4.6. PCR disease areas [OrgType 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 4.6. PCR disease areas [OrgType 1] (Top-25 disease areas, PCR 2013 to 2016)
4.7 Viruses
Figure 4.7. PCR viruses [OrgType 1] (Top-10 viruses, PCR 2013 to 2016)
Table 4.7. PCR viruses [OrgType 1] (Top-25 viruses, PCR 2013 to 2016)
4.8 Bacteria
Figure 4.8. PCR bacteria [OrgType 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 4.8. PCR bacteria [OrgType 1] (Top-25 bacteria, PCR 2013 to 2016)
4.9 Nucleic Acids
Figure 4.9. PCR nucleic acids [OrgType 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 4.9. PCR nucleic acids [OrgType 1] (Top-25 nucleic acids, PCR 2013 to 2016)
4.10 PCR Departments
Figure 4.10. PCR by end-user departments [OrgType 1] (Top-10 departments, PCR 2013 to 2016)
Table 4.10. PCR by end-user departments [OrgType 1] (Top-10 departments, PCR 2013 to 2016)
4.11 Other Techniques
Figure 4.11. Other techniques [OrgType 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 4.11. Other techniques [OrgType 1] (Top-25 other techniques, PCR 2013 to 2016)
4.12 Conclusions
CHAPTER 5. PCR BY USER DEPARTMENTS
Figure 5.1. PCR use by department (Top-10 departments, all PCR 2013 to 2016)
Table 5.1. PCR use by department (Top-25 departments, all PCR 2013 to 2016)
5.1 Organisation types
Figure 5.2. PCR organisations of [Dept 1] (Top-10 organisation, PCR 2013 to 2016)
Table 5.2. PCR organisations of [Dept 1] (Top-25 organisation, PCR 2013 to 2016)
5.2 States and Cities
Figure 5.3. PCR cities [Dept 1] (Top-10 cities, PCR 2013 to 2016)
Table 5.3. PCR cities [Dept 1] (Top-25 PCR cities, PCR 2013 to 2016)
5.3 Techniques
Figure 5.5. PCR techniques [Dept 1] (Top-10 techniques, PCR 2013 to 2016)
Table 5.5. PCR techniques [Dept 1] (Top-25 techniques, PCR 2013 to 2016)
5.4 Applications
Figure 5.5. PCR applications [Dept 1] (Top-10 applications, PCR 2013 to 2016)
Table 5.5. PCR applications [Dept 1] (Top-25 applications, PCR 2013 to 2016)
5.5 Clinical & Research
Figure 5.6. PCR clinical/research [Dept 1] (clinical/research, PCR 2013 to 2016)
Table 5.6. PCR clinical/research [Dept 1] (clinical/research, PCR 2013 to 2016)
5.6 Diseases
Figure 5.7. PCR disease areas [Dept 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 5.7. PCR disease areas [Dept 1] (Top-25 disease areas, PCR 2013 to 2016)
5.7 Viruses
Figure 5.8. PCR viruses [Dept 1] (Top-10 viruses, PCR 2013 to 2016)
Table 5.8. PCR viruses [Dept 1] (Top-25 viruses, PCR 2013 to 2016)
5.8 Bacteria
Figure 5.9. PCR bacteria [Dept 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 5.9. PCR bacteria [Dept 1] (Top-25 bacteria, PCR 2013 to 2016)
5.9 Nucleic Acids
Figure 5.10. PCR nucleic acids [Dept 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 5.10. PCR nucleic acids [Dept 1] (Top-25 nucleic acids, PCR 2013 to 2016)
5.10 Other Techniques
Figure 5.11. Other techniques [Dept 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 5.10. Other techniques [Dept 1] (Top-25 other techniques, PCR 2013 to 2016)
5.11 Conclusions
CHAPTER 6. PCR METHODS
Figure 6.1. PCR methods (Top-10 methods, all PCR 2013 to 2016)
Table 6.1. PCR methods (Top-25 methods, all PCR 2013 to 2016)
6.1 Organisation types
Figure 6.2. PCR organisations of [Method 1] (Top-10 organisation, PCR 2013 to 2016)
Table 6.2. PCR organisations of [Method 1] (Top-25 organisation, PCR 2013 to 2016)
6.2 Countries
Figure 6.3. PCR countries [Method 1] (Top-10 countries, PCR 2013 to 2016)
Table 6.3. PCR countries [Method 1] (Top-25 countries, PCR 2013 to 2016)
6.3 Organisation types
Figure 6.4. PCR organisations [Method 1] (Top-10 organisation, PCR 2013 to 2016)
Table 6.4. PCR organisations [Method 1] (Top-25 organisation, PCR 2013 to 2016)
6.4 Cities
Figure 6.6. PCR cities [Method 1] (Top-10 cities, PCR 2013 to 2016)
Table 6.6. PCR cities [Method 1] (Top-25 cities, PCR 2013 to 2016)
6.5 Clinical & Research
Figure 6.6. PCR clinical/research [Method 1] (PCR clinical/research, PCR 2013 to 2016)
Table 6.6. PCR clinical/research [Method 1] (PCR clinical/research, PCR 2013 to 2016)
6.6 Diseases
Figure 6.7. PCR disease areas [Method 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 6.7. PCR disease areas [Method 1] (Top-25 disease areas, PCR 2013 to 2016)
6.7 Viruses
Figure 6.8. PCR viruses [Method 1] (Top-10 viruses, PCR 2013 to 2016)
Table 6.8. PCR viruses of [Method 1] (Top-25 viruses, PCR 2013 to 2016)
6.8 Bacteria
Figure 6.9. PCR bacteria [Method 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 6.9. PCR bacteria of [Method 1] (Top-25 bacteria, PCR 2013 to 2016)
6.9 Nucleic Acids
Figure 6.10. PCR nucleic acids [Method 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 6.10. PCR nucleic acids [Method 1] (Top-25 nucleic acids, PCR 2013 to 2016)
6.10 Departments
Figure 6.11. PCR departments [Method 1] (Top-10 departments, PCR 2013 to 2016)
Table 6.11. PCR departments of [Method 1] (Top-25 departments, PCR 2013 to 2016)
6.11 Other Techniques
Figure 6.12. Other techniques [Method 1] (Top-10 techniques, PCR 2013 to 2016)
Table 6.12. Other techniques [Method 1] (Top-25 techniques, PCR 2013 to 2016)
6.12 Conclusions
CHAPTER 7. PCR APPLICATIONS
Figure 7.1. PCR applications (Top-10 applications, all PCR 2013 to 2016)
Table 7.1. PCR applications (Top-25 applications, all PCR 2013 to 2016)
7.1 Organisation types
Figure 7.2. PCR organisations of [App 1] (Top-10 organisations, PCR 2013 to 2016)
Table 7.2. PCR organisations of [App 1] (Top-25 organisation, PCR 2013 to 2016)
7.2 Cities
Figure 7.3. PCR cities [App 1] (Top-10 cities, PCR 2013 to 2016)
Table 7.3. PCR cities [App 1] (Top-25 cities, PCR 2013 to 2016)
7.3 Techniques
Figure 7.4. PCR techniques of [App 1] (Top-10 techniques, PCR 2013 to 2016)
Table 7.4. PCR techniques of [App 1] (Top-25 techniques, PCR 2013 to 2016)
7.4 Clinical & Research
Figure 7.5. Clinical/Research [App 1] (Clinical/Research, PCR 2013 to 2016)
Table 7.5. Clinical/Research [App 1] (Clinical/Research, PCR 2013 to 2016)
7.5 Diseases
Figure 7.7. PCR disease areas [App 1] (PCR disease areas, PCR 2013 to 2016)
Table 7.7. PCR disease areas [App 1] (Top-25 disease areas, PCR 2013 to 2016)
7.6 Viruses
Figure 7.7. PCR viruses [App 1] (Top-10 viruses, PCR 2013 to 2016)
Table 7.7. PCR viruses of [App 1] (Top-25 viruses, PCR 2013 to 2016)
7.7 Bacteria
Figure 7.8. PCR bacteria [App 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 7.8. PCR bacteria of [App 1] (Top-25 bacteria, PCR 2013 to 2016)
7.81 Nucleic Acids
Figure 7.9. PCR nucleic acids [App 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 7.9. PCR nucleic acids of [App 1] (Top-25 nucleic acids, PCR 2013 to 2016)
7.9 Departments
Figure 7.10. PCR departments [App 1] (Top-10 departments, PCR 2013 to 2016)
Table 7.10. PCR departments of [App 1] (Top-25 departments, PCR 2013 to 2016)
7.10 Other Techniques
Figure 7.11. Other techniques [App 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 7.11. Other techniques [App 1] (Top-25 other techniques, PCR 2013 to 2016)
7.11 Conclusions
CHAPTER 8. DISEASE AREAS
Figure 8.1. PCR disease areas (Top-10 disease areas, all PCR 2013 to 2016)
Table 8.1. PCR disease areas (Top-25 disease areas, all PCR 2013 to 2016)
8.1 Organisation types
Figure 8.2. PCR organisations of [Disease 1] (Top-10 organisations, PCR 2013 to 2016)
Table 8.2. PCR organisations of [Disease 1] (Top-25 organisation, PCR 2013 to 2016)
8.1 Countries
Figure 8.3. PCR countries [Disease 1] (Top-10 countries, PCR 2013 to 2016)
Table 8.3. PCR countries of [Disease 1] (Top-25 countries, PCR 2013 to 2016)
8.3 Cities
Figure 8.4. PCR cities [Disease 1] (Top-10 cities, PCR 2013 to 2016)
Table 8.4. PCR cities of [Disease 1] (Top-25 cities, PCR 2013 to 2016)
8.4 Methods
Figure 8.5. PCR methods [Disease 1] (Top-10 methods, PCR 2013 to 2016)
Table 8.5. PCR methods of [Disease 1] (Top-25 methods, PCR 2013 to 2016)
8.5 Applications
Figure 8.6. PCR application [Disease 1] (Top-10 application, PCR 2013 to 2016)
Table 8.6. PCR application of [Disease 1] (Top-25 application, PCR 2013 to 2016)
8.6 Clinical & Research
Figure 8.8. PCR Clinical/Research [Disease 1] (Clinical/Research, PCR 2013 to 2016)
Table 8.8. Clinical/Research [Disease 1] (Top-25 Clinical/Research, PCR 2013 to 2016)
8.7 Viruses
Figure 8.8. PCR viruses [Disease 1] (Top-10 viruses, PCR 2013 to 2016)
Table 8.8. PCR viruses [Disease 1] (Top-25 viruses, PCR 2013 to 2016)
8.8 Bacteria
Figure 8.9. PCR bacteria [Disease 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 8.9. PCR bacteria [Disease 1] (Top-25 bacteria, PCR 2013 to 2016)
8.9 Nucleic Acids
Figure 8.10. PCR nucleic acids [Disease 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 8.10. PCR nucleic acids [Disease 1] (Top-25 nucleic acids, PCR 2013 to 2016)
8.10 Departments
Figure 8.11. PCR departments [Disease 1] (Top-10 departments, PCR 2013 to 2016)
Table 8.11. PCR departments of [Disease 1] (Top-25 departments, PCR 2013 to 2016)
8.11 Other Techniques
Figure 8.12. Other techniques [Disease 1] (Top-10 techniques, PCR 2013 to 2016)
Table 8.12. PCR techniques of [Disease 1] (Top-25 techniques, PCR 2013 to 2016)
8.12 Conclusions
CHAPTER 9. VIRUSES
Figure 9.1. PCR viruses (Top-10 viruses, all PCR 2013 to 2016)
Table 9.1. PCR viruses (Top-25 viruses, all PCR 2013 to 2016)
9.1 Organisation types
Figure 9.2. PCR organisations of [Virus 1] (Top-10 organisations, PCR 2013 to 2016)
Table 9.2. PCR organisations of [Virus 1] (Top-25 organisation, PCR 2013 to 2016)
9.2 Cities
Figure 9.3. PCR cities [Virus 1] (Top-10 cities, PCR 2013 to 2016)
Table 9.3. PCR cities of [Virus 1] (Top-25 cities, PCR 2013 to 2016)
9.3 Methods
Figure 9.4. PCR methods [Virus 1] (Top-10 methods, PCR 2013 to 2016)
Table 9.4. PCR methods of [Virus 1] (Top-25 methods, PCR 2013 to 2016)
9.4 Applications
Figure 9.5. PCR applications [Virus 1] (Top-10 applications, PCR 2013 to 2016)
Table 9.5. PCR applications of [Virus 1] (Top-25 applications, PCR 2013 to 2016)
9.5 Clinical & Research
Figure 9.6. Clinical/Research [Virus 1] (Clinical/Research, PCR 2013 to 2016)
Table 9.6. Clinical/Research [Virus 1] (Clinical/Research, PCR 2013 to 2016)
9.6 Diseases
Figure 9.7. PCR disease areas [Virus 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 9.7. PCR disease areas [Virus 1] (Top-25 disease areas, PCR 2013 to 2016)
9.7 Bacteria
Figure 9.9. PCR bacteria [Virus 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 9.9. PCR bacteria of [Virus 1] (Top-25 bacteria, PCR 2013 to 2016)
9.8 Nucleic Acids
Figure 9.9. PCR nucleic acids [Virus 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 9.9. PCR nucleic acids [Virus 1] (Top-25 nucleic acids, PCR 2013 to 2016)
9.9 Departments
Figure 9.10. PCR departments [Virus 1] (Top-10 departments, PCR 2013 to 2016)
Table 9.10. PCR departments [Virus 1] (Top-25 departments, PCR 2013 to 2016)
9.10 Other Techniques
Figure 9.11. Other techniques [Virus 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 9.11. Other techniques [Virus 1] (Top-25 other techniques, PCR 2013 to 2016)
9.11 Conclusions
CHAPTER 10. BACTERIA
Figure 10.1. PCR viruses (Top-10 viruses, all PCR 2013 to 2016)
Table 10.1. PCR viruses (Top-25 viruses, all PCR 2013 to 2016)
10.1 Countries
Figure 10.2. PCR countries [Bacteria 1] (Top-10 countries, PCR 2013 to 2016)
Table 10.2. PCR countries [Bacteria 1] (Top-25 countries, PCR 2013 to 2016)
10.2 Organisation types
Figure 10.3 Organisation types [Bacteria 1] (Top-10 organisations, PCR 2013 to 2016)
Table 10.3. Organisation types [Bacteria 1] (Top-10 organisations, PCR 2013 to 2016)
10.3 Cities
Figure 10.4. PCR cities [Bacteria 1] (Top-10 cities, PCR 2013 to 2016)
Table 10.4. PCR cities [Bacteria 1] (Top-25 cities, PCR 2013 to 2016)
10.4 Techniques
Figure 10.5. PCR techniques [Bacteria 1] (Top-10 techniques, PCR 2013 to 2016)
Table 10.5. PCR techniques [Bacteria 1] (Top-25 techniques, PCR 2013 to 2016)
10.5 Applications
Figure 10.6. PCR applications [Bacteria 1] (Top-10 applications, PCR 2013 to 2016)
Table 10.6. PCR applications [Bacteria 1] (Top-25 applications, PCR 2013 to 2016)
10.6 Clinical & Research
Figure 10.7. Clinical/Research [Bacteria 1] (Clinical/Research, PCR 2013 to 2016)
Table 10.7. Clinical/Research [Bacteria 1] (Clinical/Research, PCR 2013 to 2016)
10.7 Diseases
Figure 10.8. PCR disease areas [Bacteria 1] (PCR disease areas, PCR 2013 to 2016)
Table 10.8. PCR disease areas [Bacteria 1] (PCR disease areas, PCR 2013 to 2016)
10.8 Viruses
Figure 10.10. PCR viruses [Bacteria 1] (Top-10 viruses, PCR 2013 to 2016)
Table 10.10. PCR viruses [Bacteria 1] (Top-25 viruses, PCR 2013 to 2016)
10.9 Nucleic Acids
Figure 10.10. PCR nucleic acids [Bacteria 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 10.10. PCR nucleic acids [Bacteria 1] (Top-25 nucleic acids, PCR 2013 to 2016)
10.10 Departments
Figure 10.11. PCR departments [Bacteria 1] (Top-10 departments, PCR 2013 to 2016)
Table 10.11. PCR departments [Bacteria 1] (Top-25 departments, PCR 2013 to 2016)
10.11 Other Techniques
Figure 10.12. Other techniques [Bacteria 1] (Top-10 techniques, PCR 2013 to 2016)
Table 10.12. Other techniques [Bacteria 1] (Top-25 techniques, PCR 2013 to 2016)
10.12 Conclusions
CHAPTER 11. CLINICAL AND RESEARCH
Figure 11.1. Clinical (Top-10 PCR methods, all PCR 2013 to 2016)
Table 11.1. Clinical (Top-25 PCR methods, all PCR 2013 to 2016)
Figure 11.2. Research (Top-10 PCR methods, all PCR 2013 to 2016)
Table 11.2. Research (Top-25 PCR methods, all PCR 2013 to 2016)
11.1 Countries
Figure 11.3. PCR countries [Clinical] (Top-10 countries, PCR 2013 to 2016)
Table 11.3. PCR countries [Clinical] (Top-25 countries, PCR 2013 to 2016)
Figure 11.4. PCR countries [Research] (Top-10 countries, PCR 2013 to 2016)
Table 11.4. PCR countries [Research] (Top-25 countries, PCR 2013 to 2016)
11.2 Organisation types
Figure 11.5. PCR organisation types [Clinical] (Top-10 organisations, PCR 2013 to 2016)
Table 11.5. PCR organisation types [Clinical] (Top-25 organisations, PCR 2013 to 2016)
Figure 11.6. PCR organisation types [Research] (Top-10 organisations, PCR 2013 to 2016)
Table 11.6. PCR organisation types [Research] (Top-25 organisations, PCR 2013 to 2016)
11.3 Cities
Figure 11.7. PCR cities [Clinical] (Top-10 cities, PCR 2013 to 2016)
Table 11.7. PCR cities [Clinical] (Top-25 cities, PCR 2013 to 2016)
Figure 11.8. PCR cities [Research] (Top-10 cities, PCR 2013 to 2016)
Table 11.8. PCR cities [Research] (Top-25 cities, PCR 2013 to 2016)
11.4 Methods
Figure 11.9. PCR methods [Clinical] (Top-10 methods, PCR 2013 to 2016)
Table 11.9. PCR methods [Clinical] (Top-25 methods, PCR 2013 to 2016)
Figure 11.11. PCR methods [Research] (Top-10 methods, PCR 2013 to 2016)
Table 11.11. PCR methods [Research] (Top-25 methods, PCR 2013 to 2016)
11.5 Applications
Figure 11.11. PCR applications [Clinical] (Top-10 applications, PCR 2013 to 2016)
Table 11.11. PCR applications [Clinical] (Top-25 applications, PCR 2013 to 2016)
Figure 11.12. PCR applications [Research] (Top-10 applications, PCR 2013 to 2016)
Table 11.12. PCR applications [Research] (Top-25 applications, PCR 2013 to 2016)
11.6 Diseases
Figure 11.13. PCR diseases [Clinical] (Top-10 diseases, PCR 2013 to 2016)
Table 11.13. PCR diseases [Clinical] (Top-25 diseases, PCR 2013 to 2016)
Figure 11.14. PCR diseases [Research] (Top-10 diseases, PCR 2013 to 2016)
Table 11.14. PCR diseases [Research] (Top-25 diseases, PCR 2013 to 2016)
11.7 Viruses
Figure 11.15. PCR viruses [Clinical] (Top-10 viruses, PCR 2013 to 2016)
Table 11.15. PCR viruses [Clinical] (Top-25 viruses, PCR 2013 to 2016)
Figure 11.16. PCR viruses [Research] (Top-10 viruses, PCR 2013 to 2016)
Table 11.16. PCR viruses [Research] (Top-25 viruses, PCR 2013 to 2016)
11.8 Bacteria
Figure 11.17. PCR bacteria [Clinical] (Top-10 bacteria, PCR 2013 to 2016)
Table 11.17. PCR bacteria [Clinical] (Top-25 bacteria, PCR 2013 to 2016)
Figure 11.18. PCR bacteria [Research] (Top-10 bacteria, PCR 2013 to 2016)
Table 11.18. PCR bacteria [Research] (Top-25 bacteria, PCR 2013 to 2016)
11.9 Nucleic Acids
Figure 11.19. PCR nucleic acids [Clinical] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 11.19. PCR nucleic acids [Clinical] (Top-25 nucleic acids, PCR 2013 to 2016)
Figure 11.20. PCR nucleic acids [Research] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 11.20. PCR nucleic acids [Research] (Top-25 nucleic acids, PCR 2013 to 2016)
11.10 Departments
Figure 11.21. PCR departments [Clinical] (Top-10 departments, PCR 2013 to 2016)
Table 11.21. PCR departments [Clinical] (Top-25 departments, PCR 2013 to 2016)
Figure 11.22. PCR departments [Research] (Top-10 departments, PCR 2013 to 2016)
Table 11.22. PCR departments [Research] (Top-25 departments, PCR 2013 to 2016)
11.11 Other Techniques
Figure 11.23. Other techniques [Clinical] (Top-10 other techniques, PCR 2013 to 2016)
Table 11.23. Other techniques [Clinical] (Top-25 other techniques, PCR 2013 to 2016)
Figure 11.24. Other techniques [Research] (Top-10 other techniques, PCR 2013 to 2016)
Table 11.24. Other techniques [Research] (Top-25 other techniques, PCR 2013 to 2016)
11.12 Conclusions
CHAPTER 12. NUCLEIC ACIDS
Figure 12.1. PCR nucleic acids (Top-10 nucleic acids, all PCR 2013 to 2016)
Table 12.1. PCR nucleic acids (Top-25 nucleic acids, all PCR 2013 to 2016)
12.1 Countries
Figure 12.2. PCR countries [Nucleic Acid 1] (Top-10 countries, PCR 2013 to 2016)
Table 12.2. PCR countries [Nucleic Acid 1] (Top-25 countries, PCR 2013 to 2016)
12.2 Organisation types
Figure 12.3. PCR organisation types [Nucleic Acid 1] (Top-10 organisations types, PCR 2013 to 2016)
Table 12.3. PCR organisation types [Nucleic Acid 1] (Top-25 organisations types, PCR 2013 to 2016)
12.3 Cities
Figure 12.4. PCR cities [Nucleic Acid 1] (Top-10 cities, PCR 2013 to 2016)
Table 12.4. PCR cities types [Nucleic Acid 1] (Top-25 cities types, PCR 2013 to 2016)
12.4 Techniques
Figure 12.5. PCR methods [Nucleic Acid 1] (Top-10 methods, PCR 2013 to 2016)
Table 12.5. PCR methods [Nucleic Acid 1] (Top-25 methods, PCR 2013 to 2016)
12.5 Applications
Figure 12.6. PCR applications [Nucleic Acid 1] (Top-10 applications, PCR 2013 to 2016)
Table 12.6. PCR applications [Nucleic Acid 1] (Top-25 applications, PCR 2013 to 2016)
12.6 Clinical & Research
Figure 12.7. Clinical/Research [Nucleic Acid 1] (clinical/research, PCR 2013 to 2016)
Table 12.7. Clinical/Research [Nucleic Acid 1] (clinical/research, PCR 2013 to 2016)
12.7 Diseases
Figure 12.8. PCR disease areas [Nucleic Acid 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 12.8. PCR disease areas [Nucleic Acid 1] (Top-25 disease areas, PCR 2013 to 2016)
12.8 Viruses
Figure 12.9. PCR viruses [Nucleic Acid 1] (Top-10 viruses, PCR 2013 to 2016)
Table 12.9. PCR viruses [Nucleic Acid 1] (Top-25 viruses, PCR 2013 to 2016)
12.9 Bacteria
Figure 12.10. PCR bacteria [Nucleic Acid 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 12.10. PCR bacteria [Nucleic Acid 1] (Top-25 bacteria, PCR 2013 to 2016)
12.10 Nucleic Acids
Figure 12.12. PCR nucleic acids [Nucleic Acid 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 12.12. PCR nucleic acids [Nucleic Acid 1] (Top-25 nucleic acids, PCR 2013 to 2016)
12.11 Departments
Figure 12.12. PCR departments [Nucleic Acid 1] (Top-10 departments, PCR 2013 to 2016)
Table 12.12. PCR departments [Nucleic Acid 1] (Top-25 departments, PCR 2013 to 2016)
12.12 Other Techniques
Figure 12.13. Other molecular techniques [Nucleic Acid 1] (Top-10 techniques, PCR 2013 to 2016)
Table 12.13. Other molecular techniques [Nucleic Acid 1] (Top-25 techniques, PCR 2013 to 2016)
12.13 Conclusions
CHAPTER 13. OTHER MOLECULAR TECHNIQUES
Figure 13.1. PCR nucleic acids (Top-10 nucleic acids, all PCR 2013 to 2016)
Table 13.1. PCR nucleic acids (Top-25 nucleic acids, all PCR 2013 to 2016)
13.1 Countries
Figure 13.2. PCR countries [Other Technique 1] (Top-10 countries, PCR 2013 to 2016)
Table 13.2. PCR countries [Other Technique 1] (Top-25 countries, PCR 2013 to 2016)
13.2 Organisation types
Figure 13.3. PCR organisation types [Other Technique 1] (Top-10 organisations, PCR 2013 to 2016)
Table 13.3. PCR organisation types [Other Technique 1] (Top-25 organisations, PCR 2013 to 2016)
13.3 Cities
Figure 13.4. PCR cities [Other Technique 1] (Top-10 cities PCR 2013 to 2016)
Table 13.4. PCR cities [Other Technique 1] (Top-25 cities PCR 2013 to 2016)
13.4 Applications
Figure 13.5. PCR applications [Other Technique 1] (Top-10 applications PCR 2013 to 2016)
Table 13.5. PCR applications [Other Technique 1] (Top-25 applications PCR 2013 to 2016)
13.5 Clinical & Research
Figure 13.6. PCR cities [Other Technique 1] (Top-10 cities PCR 2013 to 2016)
Table 13.6. PCR cities [Other Technique 1] (Top-25 cities PCR 2013 to 2016)
13.6 Diseases
Figure 13.7. PCR disease areas [Other Technique 1] (Top-10 disease areas PCR 2013 to 2016)
Table 13.7. PCR disease areas [Other Technique 1] (Top-25 disease areas PCR 2013 to 2016)
13.7 Viruses
Figure 13.8. PCR viruses [Other Technique 1] (Top-10 viruses PCR 2013 to 2016)
Table 13.8. PCR viruses [Other Technique 1] (Top-25 viruses PCR 2013 to 2016)
13.8 Bacteria
Figure 13.9. PCR bacteria [Other Technique 1] (Top-10 bacteria PCR 2013 to 2016)
Table 13.9. PCR bacteria [Other Technique 1] (Top-25 bacteria PCR 2013 to 2016)
13.9 Nucleic Acids
Figure 13.10. PCR nucleic acids [Other Technique 1] (Top-10 nucleic acids PCR 2013 to 2016)
Table 13.10. PCR nucleic acids [Other Technique 1] (Top-25 nucleic acids PCR 2013 to 2016)
13.10 Departments
Figure 13.11. PCR departments [Other Technique 1] (Top-10 departments PCR 2013 to 2016)
Table 13.11. PCR departments [Other Technique 1] (Top-25 departments PCR 2013 to 2016)
13.11 Other Techniques
Figure 13.13. Other molecular techniques [Other Technique 1] (Top-10 techniques PCR 2013 to 2016)
Table 13.13. Other molecular techniques [Other Technique 1] (Top-25 techniques PCR 2013 to 2016)
13.12 Conclusions
CHAPTER 14. DISCUSSION
14.1 Top PCR Markets and Opportunities
14.2 PCR Growth and Opportunities
14.3 PCR Qualified Prospects and Opportunities
14.4 PCR End-User Costs
14.5 Key Findings
